Approval announced by Kyowa Kirin, Ardelyx Collaboration Partner
Ardelyx to receive $30 million from Kyowa Kirin in milestone and license amendment payments and $5 million from HealthCare Royalty Partners under a Financing Agreement
https://finance.yahoo.com/news/tenapanor-hyperphosphatemia-approved-japan-081500514.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.